← Back to Search

Other

Cold Liquid Barium for Swallowing Disorders in Preterm Infants

N/A
Waitlist Available
Led By Nazeeh Hanna, MD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Infants born prematurely, as defined by birth at less than 37 weeks gestational age, referred for a videofluoroscopic swallow study (VFSS) due to suspected pharyngeal phase dysphagia.
Be younger than 18 years old
Must not have
Infants born prematurely with a corrected gestational age of 43 weeks or greater.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up <5 seconds post swallow trigger
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing whether giving preterm babies with swallowing difficulties a cold liquid can help them swallow better. The cold liquid might make their throats more sensitive, which could improve their ability to swallow. The study will also check if this method is safe for the babies. Cold stimulation has been shown to reduce airway compromise in adults with swallowing difficulties, but there is no sufficient evidence to support its use in children.

Who is the study for?
This trial is for preterm infants born before 37 weeks who are suspected to have swallowing difficulties (dysphagia) and are referred for a swallow study. Infants over a corrected age of 43 weeks or with other health issues that could affect the study's results cannot participate.
What is being tested?
The study tests if feeding cold liquid barium to preterm infants with dysphagia helps them swallow better than room temperature liquids. It measures changes in their swallowing mechanism using special X-ray videos called videofluoroscopic swallow studies, taken at different times during a 10-minute feeding period.
What are the potential side effects?
While specific side effects aren't listed, the trial will monitor safety by checking the infant's body and stomach temperatures to ensure they don't develop cold stress from the cold liquid.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My baby was born early and is suspected to have swallowing problems.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My baby was born early but is now older than 43 weeks corrected age.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~<5 seconds post swallow trigger
This trial's timeline: 3 weeks for screening, Varies for treatment, and <5 seconds post swallow trigger for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Pharyngeal Phase Dysphagia
Secondary study objectives
Laryngeal Penetration
Nasopharyngeal Reflux
Pharyngeal residue
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Cold Liquid Swallows- 5Experimental Treatment1 Intervention
Immediately following the RTS condition, a total of 5 swallows of Cold Liquid Barium was observed under fluoroscopy from an identical bottle and nipple. Images were saved electronically and labeled "CS5" for "cold swallows-5."
Group II: Cold Liquid Swallows- 10Experimental Treatment1 Intervention
After 10 minutes of feeding a cold liquid, a total of 10 swallows of Cold Liquid Barium was observed under fluoroscopy from an identical bottle and nipple. Images were saved electronically and labeled "CS10" for "cold swallows-10."
Group III: Room Temperature SwallowsActive Control1 Intervention
Once consented, each participant underwent a video fluoroscopic swallow study (VFSS). Each participant was fed room temperature thin liquid barium (Varibar® Thin Liquid Barium Sulfate for Suspension) from a standard bottle (60ml Similac® Volu-Feeder®) with an attached Similac® Infant Nipple and Ring. The swallows were assessed in real time for any swallowing dysfunction and saved electronically. These swallows were labeled "RTS" for "room temperature swallows. If no swallow dysfunction was observed, the participant became ineligible and the study ended. If swallow dysfunction was observed, the participant became eligible to complete the other arms of the study.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for swallowing disorders include temperature modification, texture modification, and swallowing exercises. The mechanism of action for temperature modification, such as using cold liquids, involves stimulating sensory receptors in the oropharynx, which can enhance the swallowing reflex and improve coordination. This is particularly relevant for patients with dysphagia, as it can lead to more effective and safer swallowing. Understanding these mechanisms helps clinicians tailor treatments to individual needs, potentially reducing the risk of aspiration and improving overall quality of life for patients with swallowing disorders.
[Treatment and rehabilitation of dysphagia following cerebrovascular disease].

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,409 Previous Clinical Trials
851,772 Total Patients Enrolled
Adelphi UniversityOTHER
5 Previous Clinical Trials
1,886 Total Patients Enrolled
Nazeeh Hanna, MDPrincipal InvestigatorNYU Winthrop Hospital
2 Previous Clinical Trials
27 Total Patients Enrolled

Media Library

Cold Liquid Barium (Other) Clinical Trial Eligibility Overview. Trial Name: NCT02935946 — N/A
Muscle Tension Dysphagia Research Study Groups: Cold Liquid Swallows- 10, Cold Liquid Swallows- 5, Room Temperature Swallows
Muscle Tension Dysphagia Clinical Trial 2023: Cold Liquid Barium Highlights & Side Effects. Trial Name: NCT02935946 — N/A
Cold Liquid Barium (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02935946 — N/A
~445 spots leftby Nov 2025